WO2007138232A3 - Utilisation du granisetron pour le traitement de sous-types de la rosacée, et compositions pharmaceutiques le contenant - Google Patents

Utilisation du granisetron pour le traitement de sous-types de la rosacée, et compositions pharmaceutiques le contenant Download PDF

Info

Publication number
WO2007138232A3
WO2007138232A3 PCT/FR2007/051360 FR2007051360W WO2007138232A3 WO 2007138232 A3 WO2007138232 A3 WO 2007138232A3 FR 2007051360 W FR2007051360 W FR 2007051360W WO 2007138232 A3 WO2007138232 A3 WO 2007138232A3
Authority
WO
WIPO (PCT)
Prior art keywords
rosacea
granisetron
treatment
sub
types
Prior art date
Application number
PCT/FR2007/051360
Other languages
English (en)
Other versions
WO2007138232A2 (fr
Inventor
Jean-Dominique Pierret
Fabrizio Dolfi
Christian Loesche
Nadege Tremel
Original Assignee
Galderma Res & Dev
Jean-Dominique Pierret
Fabrizio Dolfi
Christian Loesche
Nadege Tremel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Jean-Dominique Pierret, Fabrizio Dolfi, Christian Loesche, Nadege Tremel filed Critical Galderma Res & Dev
Publication of WO2007138232A2 publication Critical patent/WO2007138232A2/fr
Publication of WO2007138232A3 publication Critical patent/WO2007138232A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation du granisetron ou de ses sels en tant que principe actif dans une composition pharmaceutique, plus particulièrement dermatologique. De préférence, la composition est appliquée topiquement. Elle est destinée au traitement et/ou a la prévention de la rosacée papulopustuleuse, de la rosacée phymateuse et/ou de la rosacée oculaire.
PCT/FR2007/051360 2006-05-31 2007-05-31 Utilisation du granisetron pour le traitement de sous-types de la rosacée, et compositions pharmaceutiques le contenant WO2007138232A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0651983A FR2901702A1 (fr) 2006-05-31 2006-05-31 Utilisation de granisetron pour le traitement de sous-types de la rosacee, et compositions pharmaceutiques
FR0651983 2006-05-31

Publications (2)

Publication Number Publication Date
WO2007138232A2 WO2007138232A2 (fr) 2007-12-06
WO2007138232A3 true WO2007138232A3 (fr) 2008-03-27

Family

ID=37441246

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/051360 WO2007138232A2 (fr) 2006-05-31 2007-05-31 Utilisation du granisetron pour le traitement de sous-types de la rosacée, et compositions pharmaceutiques le contenant

Country Status (2)

Country Link
FR (1) FR2901702A1 (fr)
WO (1) WO2007138232A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2960152A1 (fr) * 2010-01-27 2011-11-25 Galderma Res & Dev Utilisation de modulateur de recepteurs a l'histamine de type 2 pour le traitement de la rosacee et composition les contenant

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0834731A (ja) * 1994-07-26 1996-02-06 T T S Gijutsu Kenkyusho:Kk グラニセトロン含有経皮吸収型製剤
WO2004000358A1 (fr) * 2002-06-20 2003-12-31 Amnon Sintov Systeme d'administration transdermique de medicaments
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2005058312A1 (fr) * 2003-12-10 2005-06-30 Galderma Research & Development, S.N.C. Utilisation d'ondansetron pour le traitement de l'inflammation et compositions pharmaceutiques a base d'ondansetron
US6916487B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0834731A (ja) * 1994-07-26 1996-02-06 T T S Gijutsu Kenkyusho:Kk グラニセトロン含有経皮吸収型製剤
US6916487B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2004000358A1 (fr) * 2002-06-20 2003-12-31 Amnon Sintov Systeme d'administration transdermique de medicaments
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
WO2005058312A1 (fr) * 2003-12-10 2005-06-30 Galderma Research & Development, S.N.C. Utilisation d'ondansetron pour le traitement de l'inflammation et compositions pharmaceutiques a base d'ondansetron

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JANSEN T: "Influence of the 5-HT3 receptor antagonist granisetron on erythema and flushing tendency in rosacea patients", KOSMETISCHE MEDIZIN 2005 GERMANY, vol. 26, no. 1, 2005, pages 22 - 24, XP009075700, ISSN: 1430-4031 *
WILKIN JONATHAN ET AL: "Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea.", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. JUN 2004, vol. 50, no. 6, June 2004 (2004-06-01), pages 907 - 912, XP002409907, ISSN: 0190-9622 *

Also Published As

Publication number Publication date
FR2901702A1 (fr) 2007-12-07
WO2007138232A2 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
WO2007127158A3 (fr) Modification d'absorption percutanée de matériaux topiquement actifs
WO2010078883A3 (fr) Agent de désinfection et de décontamination combiné à efficacité accrue
WO2006119283A3 (fr) Compositions anti-odeurs et utilisation therapeutique associee
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2009066457A1 (fr) Composition de préparation externe comprenant du liquide ionique à base d'acides gras en tant qu'ingrédient actif
MY143795A (en) Tetrahydropyridoindole derivatives
WO2011028965A3 (fr) Pansements médicaux antimicrobiens et protégeant les plaies et sites de cathéter
WO2008016475A3 (fr) Compositions à base de modificateurs de la réponse immunitaire et procédés
WO2009091550A3 (fr) Dérivés de 2,3-dihydroimidazo [1,2-c] quinazoline à substitution sulfone utilisés pour traiter des troubles hyperproliférants et des maladies associées à l'angiogénèse
WO2008085578A3 (fr) Compositions et dispositifs antimicrobiens et procédés d'utilisation de ceux-ci
WO2013178965A3 (fr) Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau
WO2007090661A3 (fr) Combinaison de substances actives
EP2540301A3 (fr) Procédés et compositions pharmaceutiques servant à guérir des blessures
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
MX2011012143A (es) Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas.
BR112012029739A2 (pt) polissacarídeo da semente de tamarindo para uso no tratamento de infecções microbianas
BRPI0909296A2 (pt) uso de pelo menos um princípio ativo, e, composições cosmética, farmacêutica e/ou dermatológica
WO2006021401A3 (fr) Derives de bicyclononene
WO2011076209A3 (fr) Composition pharmaceutique comprenant un mélange de solvants et un dérivé de la vitamine d ou analogue
WO2002036129A3 (fr) Traitement topique de la mastalgie
WO2007081808A3 (fr) Composes et derives pour le traitement d’etats medicaux par modulation de l’activite de la lipase hormono-sensible
WO2010042212A3 (fr) Méthodes de traitement prophylactique ou thérapeutique de la douleur à l'aide de dérivés de spicamycine
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07766127

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07766127

Country of ref document: EP

Kind code of ref document: A2